Actavis (ACT) Fairly Valued After Run-Up - Jefferies
Tweet Send to a Friend
Jefferies raised its price target Actavis (NYSE: ACT) from $120 to $133 following the Warner Chilcott plc (NASDAQ: WCRX) takeover ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


